Looking for a company to keep you eye on? This week’s edition of Options Spotlight takes a look at ^AGN^ – a struggling technical performer that has garnered the attention of the bulls.
The firm is a leading maker of eye care and skin care products; it also produces best-selling pharmaceutical Botox. Allergan also sells implants used in breast augmentation and weight-loss surgery. Its products are sold in 100 countries via direct sales and distributors.
In the Options Spotlight, I shine a light on what’s happening in the options world. In the case of Allergan, call activity has been brisk on the shares as investors attempt to call a bottom to the security’s downtrend. What’s more, options players aren’t the only ones looking for a rally in the shares. For a closer look at Allergan and its sentiment backdrop, go to schaeffersresearch.com.
To read more of our analysis on the market’s biggest stories, please visit our website at schaeffersresearch.com.
Get the best ETF setups before Wall Street – click here.
Jocelynn Drake is an analyst and financial writer in the research department at Schaeffer’s Investment Research. Ms. Drake’s comments have appeared in several media outlets including the Dow Jones Newswires, CBS MarketWatch, and Reuters.